Besides (anti) angiogenic factors, other biomarkers have been evaluated to predict preeclampsia early, including homocysteine [6], myeloperoxidase [7], placental protein 13 (PP13, a member of the galectin family) [8], and pregnancy-associated protein A (PAPP-A) [9]. The gene discussed is LGALS13; the disease is preeclampsia.